Qishen Pang

4.0k total citations
80 papers, 3.0k citations indexed

About

Qishen Pang is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Qishen Pang has authored 80 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 19 papers in Hematology and 13 papers in Cancer Research. Recurrent topics in Qishen Pang's work include DNA Repair Mechanisms (49 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Myeloid Leukemia Research (12 papers). Qishen Pang is often cited by papers focused on DNA Repair Mechanisms (49 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Myeloid Leukemia Research (12 papers). Qishen Pang collaborates with scholars based in United States, China and Australia. Qishen Pang's co-authors include Wei Du, John B. Hays, Daniel P. Sejas, Grover C. Bagby, Xiaoling Zhang, Tomas A. Prolla, R. Michael Liskay, June Li, Reena Rani and Paul R. Andreassen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Qishen Pang

78 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qishen Pang United States 33 2.3k 566 409 379 355 80 3.0k
M. Dolores Delgado Spain 31 2.1k 0.9× 353 0.6× 616 1.5× 411 1.1× 194 0.5× 68 2.8k
François Gaudet United States 16 3.5k 1.5× 468 0.8× 559 1.4× 319 0.8× 189 0.5× 23 4.1k
Liangjun Wang Taiwan 19 5.0k 2.2× 661 1.2× 426 1.0× 204 0.5× 417 1.2× 69 5.9k
Javier León Spain 34 2.9k 1.3× 543 1.0× 1.2k 2.9× 479 1.3× 77 0.2× 100 4.0k
Penelope A. Jeggo United Kingdom 23 3.1k 1.3× 834 1.5× 872 2.1× 154 0.4× 246 0.7× 33 3.6k
Debra L. Smith United States 10 3.0k 1.3× 574 1.0× 986 2.4× 162 0.4× 85 0.2× 15 4.1k
Benjamin G. Bitler United States 34 2.8k 1.2× 759 1.3× 1.1k 2.7× 118 0.3× 121 0.3× 100 3.9k
Fré Arwert Netherlands 28 3.3k 1.4× 1.1k 2.0× 405 1.0× 236 0.6× 465 1.3× 65 3.7k
Anneke B. Oostra Netherlands 25 2.6k 1.1× 768 1.4× 389 1.0× 151 0.4× 318 0.9× 37 2.9k
Zhenlin Ju United States 35 2.3k 1.0× 599 1.1× 1.3k 3.2× 95 0.3× 145 0.4× 73 3.7k

Countries citing papers authored by Qishen Pang

Since Specialization
Citations

This map shows the geographic impact of Qishen Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qishen Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qishen Pang more than expected).

Fields of papers citing papers by Qishen Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qishen Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qishen Pang. The network helps show where Qishen Pang may publish in the future.

Co-authorship network of co-authors of Qishen Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Qishen Pang. A scholar is included among the top collaborators of Qishen Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qishen Pang. Qishen Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wei, Wei Du, Xun Shang, et al.. (2018). Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization. Leukemia. 33(3). 749–761. 47 indexed citations
2.
Du, Wei, Wei Liu, Benjamin Mizukawa, et al.. (2018). A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells. Leukemia. 32(9). 2041–2046. 9 indexed citations
3.
Li, Xiaoli, et al.. (2018). Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation. Stem Cell Reports. 10(2). 339–346. 17 indexed citations
4.
Mehta, Parinda A., Tsuyoshi Fukuda, Junfang Zhao, et al.. (2017). Quercetin: A Novel Targeted Chemoprevention for Patients with Fanconi Anemia (FA). Blood. 130. 1178–1178. 4 indexed citations
5.
Zhang, Tingting, Wei Du, Satoshi H. Namekawa, et al.. (2017). Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function. Scientific Reports. 7(1). 45626–45626. 29 indexed citations
6.
Du, Wei, et al.. (2016). The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion. Leukemia. 31(2). 423–433. 14 indexed citations
7.
Du, Wei, Surya Amarachintha, Amom Ruhikanta Meetei, et al.. (2015). Fancb deficiency impairs hematopoietic stem cell function. Scientific Reports. 5(1). 18127–18127. 16 indexed citations
8.
Li, Xiaoli, Liang Li, Jie Li, et al.. (2014). Concomitant Inactivation of Foxo3a and Fancc or Fancd2 Reveals a Two-Tier Protection from Oxidative Stress-Induced Hydrocephalus. Antioxidants and Redox Signaling. 21(12). 1675–1692. 6 indexed citations
9.
Shen, Changxian, Doris A. Phelps, Hakan Çam, et al.. (2013). Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks. Cancer Research. 73(11). 3393–3401. 74 indexed citations
10.
Du, Wei, et al.. (2013). Inflammation-Mediated Notch Signaling Skews Fanconi Anemia Hematopoietic Stem Cell Differentiation. The Journal of Immunology. 191(5). 2806–2817. 17 indexed citations
11.
Du, Wei, et al.. (2013). TNF-α signaling in Fanconi anemia. Blood Cells Molecules and Diseases. 52(1). 2–11. 44 indexed citations
12.
Guo, Fukun, Wei Du, Michael O′Connor, et al.. (2013). mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells. Leukemia. 27(10). 2040–2046. 62 indexed citations
13.
Pang, Qishen & Paul R. Andreassen. (2009). Fanconi anemia proteins and endogenous stresses. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 668(1-2). 42–53. 34 indexed citations
14.
Li, June, Xiaoling Zhang, Daniel P. Sejas, & Qishen Pang. (2005). Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Leukemia Research. 29(12). 1415–1423. 48 indexed citations
15.
Zhang, Xiaoling, et al.. (2004). The Fanconi Anemia Proteins Functionally Interact with the Protein Kinase Regulated by RNA (PKR). Journal of Biological Chemistry. 279(42). 43910–43919. 40 indexed citations
16.
Wei, Haiming, et al.. (2001). [Significance of the unbalanced expression of Th1/Th2 type cytokines in human glioma].. PubMed. 23(6). 594–8. 3 indexed citations
19.
Pang, Qishen & John B. Hays. (1991). UV-B-Inducible and Temperature-Sensitive Photoreactivation of Cyclobutane Pyrimidine Dimers in Arabidopsis thaliana. PLANT PHYSIOLOGY. 95(2). 536–543. 206 indexed citations
20.
Hays, John B., Eric J. Ackerman, & Qishen Pang. (1990). Rapid and Apparently Error-Prone Excision Repair of Nonreplicating UV-Irradiated Plasmids in Xenopus laevis Oocytes. Molecular and Cellular Biology. 10(7). 3505–3511. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026